DelMar Pharmacueticals Retains Sichenzia Ross Friedman Ference as Their Designated Advisor for Disclosure on OTCQX Exchange

Sichenzia Ross Friedman Ference LLP Serves as DelMar Pharmacueticals ‘ Designated Advisor for Disclosure on OTCQX Exchange

PRESS RELEASE – December 2, 2014 — Global Newswire

New York based securities and corporate law firm, Sichenzia Ross Friedman Ference LLP announced today that it has served DelMar Pharmaceuticals Inc. (OTCQX: DMPI), a clinical and commercial stage drug development company, as their Designated Advisor for Disclosure (“DAD”) on their listing on the OTCQX marketplace exchange.

About Sichenzia Ross Friedman Ference LLP
Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.